Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Mr. Forthright who wrote (1274)	6/18/1998 5:05:00 PM
From: Richard B. Haenisch	Read Replies (2) \| Respond to of 5402

FINAL TALLY! BID 0.9688 ASK 1.0313 TTL VOLUME 848,100 516,800 BUYS 331,300 SELLS RATIO 5:3 BUYS OVER SELLS BIGGEST BUY 25,000 SHARES AT 1 1/32 BIGGEST SELL 30,000 SHARES AT 1 -------------------------------------------------------------------- SINCE 6/11 3,122,800 SHARES BUY 1,936,500 SHARES SELL RATIO 3:2 BUYS OVER SELLS BIGGEST BUY ON 6/16 25,000 SHARES AT $1.00 BIGGEST SELL ON 6/11 95,000 SHARES AT $0.615 RICO

To: Mr. Forthright who wrote (1274)	6/18/1998 7:47:00 PM
From: Andrew H	Read Replies (2) \| Respond to of 5402

>>Do you know why rocketeer1 did what he did?<< Ok, I'll bite, just what did rocketeer1 do? BTW, have you checked the research thread? Chirodoc has reprinted some interesting information on the company and its product. The product certainly appears to be genuine, although odds remain against them bringing the product to market. Let's give credit where it is due, they got the funding for animal trials. If it is really 30M as macker says, that is very impressive, although certainly excessive for animal trials and one wonders why they would not report that figure in the release. IF they got 30M for research purposes, they may actually be undervalued at 1, since many biotechs who never get a product through the FDA have a much greater market cap than SGNC. Let us see how things unfold.